Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:18 PM
Ignite Modification Date:
2025-12-24 @ 4:18 PM
NCT ID:
NCT01834066
Eligibility Criteria:
Inclusion Criteria:
* Patient with Diagnose of Duchenne Muscular Dystrophy.
* Aged in between 6 to 25 Years.
* Willingness to undergo Bone Marrow derived Autologous cell Therapy.
* Ability to comprehend the explained protocol and thereafter give an informed consent as well as sign the required Informed Consent form(ICF) for the study.
* Ability and willingness to regular visit to hospital for protocol procedures and follow up
Exclusion Criteria:
* Patient who is not Diagnose of Duchenne Muscular Dystrophy.
* Patient with History of Immunodeficiency HIV+,Hepatitis B ,HBV and TPPA+,Tumor Markers+
* History of Life threatening allergic or immune -Mediated Reaction.
* the site of bone marrow aspiration potentially limiting Procedure.
* Alcohol and drug abuse / dependence.
* Patients with History of Hypertension and Hypersensitive.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
25 Years
Study:
NCT01834066
Study Brief:
Protocol Section:
NCT01834066